Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $250.92M.
ENTERPRISE VALUE (EV)
$250.92M
MacroGenics, Inc.
Market Cap
$232.96M
Enterprise Value (EV)
$250.92M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| MacroGenics, Inc. (MGNX) | $232.96M | $250.92M |
| InflaRx N.V. (IFRX)vs › | $231.99M | $65.60M |
| BioAge Labs Inc. (BIOA)vs › | $231.49M | $160.36M |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $234.48M | $225.61M |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | $117.75M |
| Utah Medical Products, Inc. (UTMD)vs › | $235.24M | $235.43M |
| Invivyd, Inc. (IVVD)vs › | $237.22M | $85.53M |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.84M | $136.25M |
| Biodesix, Inc. (BDSX)vs › | $227.77M | $269.57M |
| Quantum-Si incorporated (QSI)vs › | $238.38M | $217.98M |
Market Cap
$232.96M
Total Debt
$75.18M
Cash
$57.22M
Enterprise Value
$250.92M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
